Gastroenterology and Liver

Welcome Message

Dear Esteemed Participants,

On behalf of the organizing committee, it is our great pleasure to welcome you to the 5^th International Conference on Gastroenterology and Liver, scheduled for June 29–30, 2026, in Paris, France.

This year’s conference will unite global experts in gastroenterology, hepatology, internal medicine, and digestive health to share the latest advancements, innovative research, and transformative approaches in the prevention, diagnosis, and management of gastrointestinal and liver disorders. With digestive and hepatic diseases posing major global health challenges, this conference serves as a vital platform for collaboration and innovation toward improving clinical outcomes and advancing patient care.

Whether you are joining as a speaker, delegate, researcher, or exhibitor, we invite you to actively participate in discussions, network with peers, and contribute to the collective vision of advancing gastroenterology and liver medicine worldwide.

We look forward to welcoming you to Paris for an engaging experience filled with learning, inspiration, and global collaboration.

Warm regards,
Organizing Committee

About Conference

The 5^th International Conference on Gastroenterology and Liver will be held on June 29–30, 2026, in Paris, France, under the theme “Innovations in Gastroenterology and Liver Care: Advancing Research, Treatment, and Global Health.”

This global event brings together leading scientists, clinicians, surgeons, researchers, academicians, and healthcare professionals dedicated to improving gastrointestinal and hepatic health. The conference will feature keynote sessions, symposia, workshops, and interactive panels covering a broad spectrum of topics — including gastrointestinal oncology, endoscopic innovations, liver transplantation, microbiome research, viral hepatitis, metabolic liver diseases, and advancements in non-invasive diagnostics.

By integrating clinical expertise with research insights, the event aims to bridge the gap between scientific discovery and real-world application, fostering new partnerships that will shape the future of gastroenterology and hepatology.

CONFERENCE AGENDA

Registration & Welcome Kit: Delegates will begin by registering and collecting conference kits, badges, and the detailed program. Early check-in is encouraged for a smooth start.

Opening Ceremony & Keynote Session: The conference opens with welcome remarks from the organizing committee, followed by keynote addresses from global experts in gastroenterology and hepatology.

Scientific Sessions: Parallel sessions will explore topics such as inflammatory bowel disease, liver fibrosis, gastrointestinal cancers, endoscopic advancements, liver regeneration, and gut microbiome research.

Poster & E-Poster Presentations: Researchers and students will present innovative studies during interactive poster walks and digital poster sessions, fostering engagement and feedback.

Networking Breaks & Exhibition: Tea/coffee breaks and industry exhibitions will provide opportunities to interact with fellow participants, explore products, and build collaborations.

Conference Lunch & Closing Ceremony: Delegates can connect over lunch while exchanging ideas. On the final day, best oral and poster awards will be presented, followed by certificates and closing remarks.

Optional Activities: Special networking dinners and guided Paris city tours will offer attendees a blend of cultural experience and professional engagement.

Why to Attend?

Attending this conference offers a blend of knowledge, networking, and opportunity:

• Gain deep insights into the latest gastroenterology and liver strategies and innovations.
• Engage with leading gastroenterologists, hepatologists, clinical researchers, and key decision-makers shaping digestive and liver health across Europe and beyond.
• Strengthen professional networks to support collaborations, research partnerships, and institutional linkages.
• Present your work to an international audience and enhance your academic and professional visibility.
• Access sessions focused on cutting-edge topics such as advanced endoscopic innovations, liver disease diagnostics, gastrointestinal biomarkers, hepatology-based therapeutics, microbiome research, digestive system imaging, and emerging clinical management pathways.
• Participate in workshops that translate evidence into practice, offering tools that can be implemented in real-world settings.

Experience the cultural richness of Paris while being part of one of Europe’s most impactful health conferences.

Participation / Presentation Options

To ensure accessibility for global researchers and clinical professionals, the Summit offers multiple participation formats designed to support scientific exchange, visibility, and collaboration.

Oral Presentation: Showcase comprehensive studies, clinical trial outcomes, and novel gastro-liver biomarkers, advanced endoscopic or imaging techniques, hepatology-focused diagnostics, or innovative therapeutic methodologies. Oral presenters will engage in interactive Q&A sessions with leading experts in gastroenterology and liver research.

Poster Presentation: Ideal for early-stage studies, pilot data, method development, and exploratory work. Presenters engage with delegates during dedicated poster viewing and networking segments.

Virtual Presentation: A flexible option for participants unable to travel. Present your work online and receive equal recognition, certificates, and publication benefits as onsite presenters.

Delegate Participation: For professionals who wish to attend without presenting. Delegates gain full access to all scientific sessions, keynote talks, workshops, and networking activities.

Exhibitor & Sponsorship Opportunities: Designed for biotech firms, diagnostic companies, CROs, universities, and healthcare technology providers. Exhibitors can showcase products, services, and innovations to a global audience.

PARTICIPATION BENEFITS

Knowledge Enhancement & Skill Development:

• Learn from global leaders in gastroenterology, hepatology, precision therapeutics, advanced diagnostics, and translational digestive health research.
• Gain insights from keynote lectures, scientific sessions, expert panels, and hands-on workshops.
• Explore breakthroughs in gut–liver axis omics, non-invasive liver biopsy technologies, AI-enhanced GI diagnostics, and data-driven approaches in clinical gastroenterology and hepatology.

Global Networking Opportunities:

• Meet researchers, clinicians, industry experts, and innovators from over 40 countries.
• Build partnerships for joint projects, publications, grants, and institutional collaborations.
• Connect with peers, mentors, and future employers in both academic and industrial settings.

Presentation & Publication Advantages:

Present your research through Oral, Poster, or Virtual formats.

Receive:

• Certificate of Presentation
• Certificate of Participation
• Official conference recognition

Selected abstracts may be included in conference proceedings or associated publications.

Early submissions receive priority scheduling and enhanced visibility.

Career Growth & Professional Development:

• Strengthen your academic profile and CV with participation in a globally recognized summit.
• Gain insights into emerging clinical research trends in gastroenterology and hepatology, biomarker development and validation workflows, and evolving regulatory pathways for digestive and liver health innovations.
• Attend sessions on scientific leadership, research communication, and healthcare innovation.

Diverse Session Formats:

• Keynote sessions
• Scientific oral presentations
• Poster exhibitions
• Panel debates
• Specialized technical workshops
• Industry demonstrations

Each session is designed to encourage interactive learning and cross-disciplinary collaboration.

Resources & Post-Conference Access:

• Access recorded sessions (virtual and select categories).
• Download speaker presentations, session summaries, and conference materials.
• Continue networking through post-event communication channels.

Visa Assistance & Flexible Participation:

• Receive official invitation letters for visa processing.
• If travel is not possible, participants may switch to virtual mode or transfer registration as per policy.
• Hybrid options ensure participation regardless of travel restrictions.

Institutional & Organizational Benefits:

• Enhance institutional visibility through international representation.
• Explore collaboration opportunities with global research groups and industry partners.
• Identify new technologies, clinical tools, and research advancements for institutional growth.

Cultural & Experiential Value (Onsite Participants):

• Experience Paris—its culture, science, cuisine, and historic landmarks.
• Take part in networking dinners, social gatherings, and optional city tours.
• Combine scientific enrichment with a memorable international travel experience.

Certification & Recognition:

All participants receive:

• Certificate of Participation
• Certificate of Presentation (for presenters)
• Official endorsement from the 5^th International Conference on Gastroenterology and Liver

These recognitions support academic portfolios, job applications, and future grant proposals.

Abstract Review Process

Our abstract review process ensures academic rigor and fair evaluation:

Submission: Authors submit abstracts through the official online portal.

Pre-Screening: The editorial team verifies topic relevance, clarity, and structure.

Double-Blind Evaluation: Each abstract is reviewed by two independent experts specializing in gastroenterology and liver or related fields.

Scoring Criteria:

• Scientific merit and originality
• Practical implications for gastroenterology and liver
• Methodological accuracy
• Relevance to conference themes

Decision & Notification: Accepted abstracts are assigned to Oral, Poster, or Virtual Presentation categories. Feedback and revision suggestions may be offered where applicable.

Early Acceptance Advantage: Early submissions are given priority in program scheduling, allowing authors to secure preferred presentation slots.

VISA Process

We support all international participants in successfully completing their visa application process. Once your registration is confirmed, the organizing committee will provide:

• A formal Invitation Letter
• Accommodation confirmation (if booked through the conference)
• A detailed conference schedule
• Proof of registration and payment

These documents assist in meeting the requirements of the French Embassy or Consulate in your region.

General Visa Requirements

Participants may be asked to provide:

• A valid passport
• Completed visa application form
• Invitation letter from the conference
• Proof of accommodation and travel itinerary
• Registration confirmation

We strongly recommend applying 6–8 weeks in advance to avoid last-minute complications.

In Case of Visa Rejection: Refund & Participation Options:

We understand that visa outcomes vary from country to country. Therefore, our policy is designed to support you:

• If your visa is rejected, you may switch to Virtual Presentation or Virtual Participation without any deduction.
• If you prefer to request a refund, the organizing committee will process it after receiving the official visa rejection letter from the embassy or consulate.
• Refund requests must be submitted within 10 days of receiving the rejection notice.
• Processing timelines for refunds are typically 2–3 weeks.
• Registration can also be transferred to the next edition of the conference without additional fees if preferred.

This ensures that your research and contribution remain part of the scientific program—even if you cannot travel physically.

Market Analysis

The global gastroenterology and hepatology market is experiencing rapid growth, driven by increasing prevalence of digestive and liver disorders, lifestyle-related diseases, and advancements in medical technology.

The global gastrointestinal therapeutics market is projected to exceed USD 70 billion by 2030, fueled by innovations in biologics and personalized medicine.

The liver disease diagnostics and treatment market is expected to grow at a CAGR of over 6%, driven by rising cases of non-alcoholic fatty liver disease (NAFLD), hepatitis, and liver cancer.

Endoscopy and minimally invasive technology adoption continues to expand, enhancing early detection and patient recovery rates.

Microbiome-based therapies and AI-driven diagnostic tools are emerging as transformative solutions in digestive healthcare.

Increasing awareness of preventive gastroenterology and liver health programs is fostering new opportunities in both clinical and research sectors.

The conference provides a strategic platform for medical professionals, researchers, and industry stakeholders to align with these evolving trends and contribute to global progress in gastrointestinal and liver health.